| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1.9 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 19 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 25 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 27 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 32 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 33 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 35 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 39 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 49 | peak heights | Method Blank |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 236 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 284 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 326 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 348 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 358 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 368 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 373 | peak heights | QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 748 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 844 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1188 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1264 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1316 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1596 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 1661 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2142 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2147 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2251 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2301 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2609 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2685 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2689 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2729 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2749 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2785 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2788 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2808 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2821 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 2852 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3110 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3166 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3313 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3675 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3717 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3737 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3754 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3816 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3916 | peak heights | Pool QC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 3982 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 4061 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 4483 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 4646 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 4656 | peak heights | MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 4814 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 5116 | peak heights | TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 5206 | peak heights | Control TNT |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 7486 | peak heights | Control MHC |
| Reversed phase POSITIVE ION MODE | Acylcarnitine(12:0) | 15243 | peak heights | Control TNT |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|